UBAC2

Across TCGA pan-cancer cohorts, UBAC2 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated UBAC2 data layer compared with 27 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher UBAC2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated UBAC2 expression acts as an unfavorable survival marker.

SCLC, SKCM, and HNSC are the cancer types where UBAC2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	IV	0.137	0.548	.004	12	view →
SKCM	OS	Median	All	0.226	0.789	<.001	9	view →
HNSC	DFS	Median	All	0.098	0.710	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

UBAC2–SCLC (OS)

Open the SCLC breakdown →